[1]冯 湧.新一代抗凝血药阿加曲班的临床应用进展[J].医学信息,2018,31(02):43-45.[doi:10.3969/j.issn.1006-1959.2018.02.015]
　FENG Yong.Progress in Clinical Application of the New Generation Anticoagulant Agatripine[J].Journal of Medical Information,2018,31(02):43-45.[doi:10.3969/j.issn.1006-1959.2018.02.015]
点击复制

新一代抗凝血药阿加曲班的临床应用进展()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年02期
页码:
43-45
栏目:
综述
出版日期:
2018-01-15

文章信息/Info

Title:
Progress in Clinical Application of the New Generation Anticoagulant Agatripine
文章编号:
1006-1959（2018）02-0043-03
作者:
冯 湧
天津港口医院药剂科，天津 300450
Author(s):
FENG Yong
Department of Pharmacy,Tianjin Port Hospital,Tianjin 300450,China
关键词:
阿加曲班; 急性脑梗死; 肾脏替代治疗; 静脉血栓; 心肌梗死
Keywords:
Key words：Agadacan; Acute cerebral infarction; Renal replacement therapy; Venous thrombosis; Myocardial infarction
分类号:
R96
DOI:
10.3969/j.issn.1006-1959.2018.02.015
文献标志码:
A
摘要:
阿加曲班作为新一代的抗凝血药，可抑制血凝块的结合并溶解凝血酶。相对于低分子肝素等其他抗凝血剂而言，它具有无抗原性，构效关系明确，临床使用安全，临床药动学半衰期短等特点。随着研究不断深入，阿加曲班的应用前景将会更为广泛。
Abstract:
Abstract：Argatroban can inhibit the binding of blood clots and dissolve thrombin as a new generation of anti clotting drugs.Compared with low molecular weight heparin and other anticoagulants,it has no antigenicity,clear structure-activity relationship,safe for clinical use and pharmacokinetic characteristics of short half-life of clinical medicine.With the development of the application research,prospects of argatroban is more extensive.

参考文献/References:

[1]赵志权，徐瑾.阿加曲班在血液净化康宁治疗中的应用[J].内科,2016,11(2):211-213,235.
[2]王彦云,王珩.阿加曲班治疗急性脑梗死的临床研究进展[J].中西医结合心脑血管病杂志,2015,13(8):995-997.
[3]朱晓冬,常宝成,程焱.阿加曲班临床应用进展[J].中国医师进修杂志,2014,37(19):73-75.
[4]王玉华.阿加曲班联合银杏达莫治疗急性脑梗死的疗效分析[J].中国实用神经疾病杂质,2015,18(12):79-80.
[5]李静,张微微,李莹.阿加曲班对急性脑梗死患者血小板功能的影响[J].中华老年心脑血管病杂志,2011,13(6):541-543.
[6]刘君,张冠群,崔晓.阿加曲班治疗急性进展性脑梗死的临床观察[J].卒中与神经疾病,2014,21(1):45-47.
[7]赵虹,张惊宇,杨子超,等. 阿加曲班联合巴曲酶治疗急性脑梗死的临床观察[J].中国医师进修杂志,2010,33(34):49-50.
[8]牛忠江,尹运佳,吕秀玉,等.阿加曲班和依达拉奉联合应用治疗急性脑梗死的临床研究[J].2016,38(1):96-98.
[9]刘星星.阿加曲班治疗急性缺血性脑卒中50例临床分析[J].临床合理用药杂志,2016,9(8):39.
[10]曹芳芳,张海涛,冯雪,等.阿加曲班在肾脏替代治疗中应用的Meta分析[J].中国医学科学院学报,20l3 35(6):667-67l.
[11]赵志权,磨红,蒙洁英,等.阿加曲班与低分子肝素在连续性血液净化治疗抗凝中的对比研究[J].实用医学杂志,2010,26(11):2006-2008.
[12]杨旭,田密,李德天.阿加曲班在血液净化治疗中的应用[J].实用药物与临床,2014,17(6):684-687.
[13]杨嘉琳,伍丽婵,廖广园,等.枸橼酸钠与阿加曲班在危重患者连续性静脉-静脉血液滤过治疗中的抗凝效果比较[J].解放军医药杂志,2016,28(2):77-81,88.
[14]谢小菲,李晶晶,纪勤炯,等.阿加曲班联合尿激酶治疗下肢深静脉血栓的临床效果观察[J].安徽医学,2014,35(12):1679-1681.
[15]庄志浩,高毅.阿加曲班联合尿激酶治疗急性下肢深静脉血栓的临床研究[J].重庆医学,2012,41(29):3064-3065,3067.
[16]何志婷,史珂慧,刘华,等.阿加曲班预防半永久中心静脉导管血栓形成的疗效研究[J].中国血液净化,2014,13(9):669-672.
[17]戴闽,罗彩东,刘云兵,等.国产阿加曲班与比伐卢定在高出血风险急性心肌梗死患者急诊经皮冠状动脉介入治疗中临床疗效及安全性的对比研究[J].实用心脑肺血管病杂志,2015,23(10):17-20.
[18]田峰,于虎,陈韵岱,等.国产阿加曲班在择期经皮冠状动脉介入治疗中应用的安全性和有效性[J].中华心血管病杂志,2013, 41(6):480-483.
[19]庞雅玲,蒋淑琰,王养维,等.阿加曲班联合葛根素治疗糖尿病动脉硬化闭死症疗效观察[J].现代中西医结合杂志,2016,25(16):1766-1768.
[20]李娜,康一生,于立新,等.阿加曲班预防儿童亲属活体肝移植术后早期血栓并发症[J].中华器官移植杂志,2015,36(6):351-355.

相似文献/References:

[1]王 伟,宫秀群,余 亮.阿替普酶治疗急性脑梗死患者临床转归的影响因素[J].医学信息,2022,35(11):84.[doi:10.3969/j.issn.1006-1959.2022.11.022]
　WANG Wei,GONG Xiu-qun,YU Liang.The Influencing Factors of Clinical Outcome in Patients with Acute Cerebral Infarction Treated with Alteplase[J].Journal of Medical Information,2022,35(02):84.[doi:10.3969/j.issn.1006-1959.2022.11.022]
[2]钱朝庆,刘 淼,王家平,等.肾病综合征合并肾静脉血栓应用阿加曲班疗效评价[J].医学信息,2018,31(21):135.[doi:10.3969/j.issn.1006-1959.2018.21.038]
　QIAN Chao-qing,LIU Miao,WANG Jia-ping,et al.Clinical Efficacy Evaluation of Argatroban in Nephrotic Syndrome with Renal Vein Thrombosis[J].Journal of Medical Information,2018,31(02):135.[doi:10.3969/j.issn.1006-1959.2018.21.038]
[3]刘 然.头颅MRI-DWI病灶数量及部位对脑梗死复发预测意义[J].医学信息,2018,31(22):172.[doi:10.3969/j.issn.1006-1959.2018.22.052]
　LIU Ran.The Significance of the Number and Location of MRI-DWI Lesions in Predicting the Recurrence of Cerebral Infarction[J].Journal of Medical Information,2018,31(02):172.[doi:10.3969/j.issn.1006-1959.2018.22.052]
[4]徐润鸿.血府逐瘀汤联合阿托伐他汀钙治疗急性脑梗死的临床观察[J].医学信息,2019,32(05):165.[doi:10.3969/j.issn.1006-1959.2019.05.054]
　XU Run-hong.Clinical Observation on Treatment of Acute Cerebral Infarction with Xuefu Zhuyu Decoction Combined with Atorvastatin Calcium[J].Journal of Medical Information,2019,32(02):165.[doi:10.3969/j.issn.1006-1959.2019.05.054]
[5]王丹丹,王学建.动脉自旋标记在急性脑梗死中的应用[J].医学信息,2019,32(12):102.[doi:10.3969/j.issn.1006-1959.2019.12.031]
　WANG Dan-dan,WANG Xue-jian.Application of Arterial Spin Labeling in Acute Cerebral Infarction[J].Journal of Medical Information,2019,32(02):102.[doi:10.3969/j.issn.1006-1959.2019.12.031]
[6]赵宏伟.急性脑梗死的危险因素及临床诊治研究[J].医学信息,2019,32(18):44.[doi:10.3969/j.issn.1006-1959.2019.17.015]
　ZHAO Hong-wei.Risk Factors and Clinical Diagnosis and Treatment of Acute Cerebral Infarction[J].Journal of Medical Information,2019,32(02):44.[doi:10.3969/j.issn.1006-1959.2019.17.015]
[7]陶 林,马 婷.丁苯酞注射液、胶囊序贯疗法辅治急性进展性脑梗死的 疗效及其对神经功能的影响[J].医学信息,2019,32(18):135.[doi:10.3969/j.issn.1006-1959.2019.18.045]
　TAO Lin,MA Ting.Efficacy of Butylphthalide Injection and Capsule Sequential Therapy in the Treatment of Acute Progressive Cerebral Infarction and Its Effect on Neurological Function[J].Journal of Medical Information,2019,32(02):135.[doi:10.3969/j.issn.1006-1959.2019.18.045]
[8]朱丽娜,王宗立,顾萌萌.UA、Hcy和FIB与颈动脉粥样硬化斑块及 脑梗死关系的分析[J].医学信息,2019,32(18):173.[doi:10.3969/j.issn.1006-1959.2019.18.061]
　ZHU Li-na,WANG Zong-li,GU Meng-meng.Analysis of the Relationship Among UA, Hcy，FIB and Carotid Atherosclerotic Plaque， Cerebral Infarction[J].Journal of Medical Information,2019,32(02):173.[doi:10.3969/j.issn.1006-1959.2019.18.061]
[9]陈 曦,刘 楠,张洪淞.尤瑞克林治疗急性脑梗死患者的临床效果[J].医学信息,2019,32(12):156.[doi:10.3969/j.issn.1006-1959.2019.12.052]
　CHEN Xi,LIU Nan,ZHANG Hong-song.Clinical Effect of Ureklin in Patients with Acute Cerebral Infarction[J].Journal of Medical Information,2019,32(02):156.[doi:10.3969/j.issn.1006-1959.2019.12.052]
[10]陈 曦,刘 楠,张洪淞.马来酸桂哌齐特联合尤瑞克林在急性脑梗死患者中的疗效[J].医学信息,2019,32(14):142.[doi:10.3969/j.issn.1006-1959.2019.14.046]
　CHEN Xi,LIU Nan,ZHANG Hong-song.Efficacy of Cinepazide Maleate Combined with Uricillin in Patients with Acute Cerebral Infarction[J].Journal of Medical Information,2019,32(02):142.[doi:10.3969/j.issn.1006-1959.2019.14.046]
[11]陈建新.阿加曲班注射液治疗急性脑梗死的疗效及对血清VEGF、GLUT-1水平的影响[J].医学信息,2018,31(19):5.[doi:10.3969/j.issn.1006-1959.2018.19.002]
　CHEN Jian-xin.Effect of Argatroban Injection on Acute Cerebral Infarction and Its Effect on Serum VEGF and GLUT-1 Levels[J].Journal of Medical Information,2018,31(02):5.[doi:10.3969/j.issn.1006-1959.2018.19.002]
[12]褚春沐.阿加曲班联合阿替普酶静脉溶栓治疗急性脑梗死的效果及对脑血管储备功能的影响[J].医学信息,2022,35(13):133.[doi:10.3969/j.issn.1006-1959.2022.13.031]
　CHU Chun-mu.Effect of Argatroban Combined with Alteplase Intravenous Thrombolysis on Acute Cerebral Infarction and its Effect on Cerebrovascular Reserve Function[J].Journal of Medical Information,2022,35(02):133.[doi:10.3969/j.issn.1006-1959.2022.13.031]
[13]赵东慧,王 楠,杨思远.阿加曲班联合阿替普酶静脉溶栓治疗急性脑梗死的疗效及对脑血管储备功能的影响[J].医学信息,2023,36(13):151.[doi:10.3969/j.issn.1006-1959.2023.13.033]
　ZHAO Dong-hui,WANG Nan,YANG Si-yuan.Effect of Argatroban Combined with Alteplase Intravenous Thrombolysis on Acute Cerebral Infarction and its Effect on Cerebrovascular Reserve Function[J].Journal of Medical Information,2023,36(02):151.[doi:10.3969/j.issn.1006-1959.2023.13.033]

更新日期/Last Update: 2018-02-15